일회용 바이오프로세스 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

Persistence Market Research has recently released a comprehensive report on the global Single-Use Bioprocess Systems Market. The report provides a detailed analysis of the market dynamics, highlighting key drivers, trends, opportunities, and challenges shaping its growth trajectory.

Key Insights:

• Single-Use Bioprocess Systems Market Size (2024E): USD 7.59 Billion
• Projected Market Value (2032F): USD 22.20 Billion
• Global Market Growth Rate (CAGR 2024 to 2032): 14.4%

Single-Use Bioprocess Systems Market - Report Scope:

Single-use bioprocess systems play a pivotal role in biopharmaceutical manufacturing, offering advantages such as cost-effectiveness, reduced cross-contamination risk, and operational flexibility. These systems encompass a range of products, including bioreactors, mixers, connectors, tubing, and filtration systems, designed for single-use applications across biomanufacturing processes.

Market Growth Drivers:

The global single-use bioprocess systems market is driven by several factors, including the increasing adoption of biologics in pharmaceutical development, rising demand for flexible and scalable manufacturing solutions, and regulatory support for single-use technologies to streamline production and ensure product safety. Technological advancements in single-use components, such as sensors and control systems, enhance process efficiency and product quality, further propelling market growth.

Market Restraints:

Despite robust growth prospects, the market faces challenges related to concerns over plastic waste management and the need for stringent quality control measures to maintain product integrity throughout the manufacturing process. Regulatory compliance and standardization issues across different geographies also pose barriers to market expansion.

Market Opportunities:

The single-use bioprocess systems market presents significant growth opportunities driven by innovations in biopharmaceutical manufacturing technologies, increasing outsourcing of biomanufacturing activities, and the expansion of biopharmaceutical pipelines globally. Strategic collaborations between biopharmaceutical companies and technology providers to develop customized single-use solutions and expand manufacturing capacities are expected to unlock new growth avenues.

Competitive Intelligence and Business Strategy:

Leading players in the global single-use bioprocess systems market, including Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Danaher Corporation, and Repligen Corporation, focus on product innovation, strategic partnerships, and geographical expansion to strengthen their market presence. These companies invest in R&D to develop next-generation bioprocessing technologies and collaborate with biopharmaceutical manufacturers to integrate advanced single-use solutions into their production workflows.

Key Companies Profiled:

• Thermo Fisher Scientific
• Sartorius Stedim Biotech
• Danaher Corporation
• Merck KGaA (Millipore)
• Corning
• Avantor
• CESCO Bioengineering Co. Ltd.
• PBS Biotech, Inc.
• Distek, Inc.
• Eppendorf AG
• Celltainer Biotech B.V.
• Getinge (Applikon Biotechnology)
• Cellexus Ltd.
• Parker Hannifin Corp
• Mettler-Toledo International, Inc.

Single-Use Bioprocess Systems Industry Research Segmentation

By Component:

• Bioreactors
• Mixers
• Bioprocess Containers
• Transfer and Storage Bags
• Sampling Systems
• Filtration Systems
• Chromatography Columns
• Probes & Sensors
• Tubing Assemblies
• Connectors & Clamps
• Filling Systems

By Application:

• Research & Development (R&D)
• GMP and Commercial Production

By End User:

• Biopharmaceutical Companies
• Contract Research Organizations
• Contract Manufacturing Organizations
• Research Institutes

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion And Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Development Trends

4. Key Inclusions

• 4.1. Global Healthcare Industry Outlook
• 4.2. Push Towards Continuous Manufacturing Processes
• 4.3. Key Products USP/Feature Analysis
• 4.4. Key Promotional Strategies By Manufacturers
• 4.5. Technological Advancements
• 4.6. Product Adoption Analysis by Region
• 4.7. Porters Analysis
• 4.8. PESTLE Analysis
• 4.9. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Global Healthcare Expenditure Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Adoption of Single-Use Bioprocess Systems
  • 5.2.2. Healthcare Research and Development Activities
  • 5.2.3. Per Capita Healthcare Expenditure
  • 5.2.4. Advancement in Technology for Single-use Bioprocess Systems
  • 5.2.5. Strategic Developments by Key Players
  • 5.2.6. Cost of the Products and Raw Materials
• 5.3. Advancements in Single-Use Bioprocess Systems
• 5.4. Market Dynamics
  • 5.4.1. Drivers
  • 5.4.2. Restraints
  • 5.4.3. Opportunity Analysis

6. COVID19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Component
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Region

7. Global Single-use Bioprocess Systems Market Volume ('000 Unit) Analysis 2019-2023 and Forecast, 2024-2032

• 7.1. Historical Market Volume ('000 Unit) Analysis, 2019-2023
• 7.2. Current and Future Market Volume ('000 Unit) Projections, 2024-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Single-use Bioprocess Systems Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark

9. Global Single-use Bioprocess Systems Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032, By Component

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume ('000 Unit) Analysis By Component, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Unit) Analysis and Forecast By Component, 2024-2032
  • 10.3.1. Bioreactors
    • 10.3.1.1. Cell Culture Bioreactors
    • 10.3.1.2. Fermentation Bioreactors
  • 10.3.2. Mixers
  • 10.3.3. Bioprocess Containers
  • 10.3.4. Transfer and Storage Bags
  • 10.3.5. Sampling Systems
  • 10.3.6. Filtration Systems
  • 10.3.7. Chromatography Columns
  • 10.3.8. Probes & Sensors
  • 10.3.9. Tubing Assemblies
  • 10.3.10. Connectors & Clamps
  • 10.3.11. Filling Systems
• 10.4. Market Attractiveness Analysis By Component

11. Global Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032, By Application

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2032
  • 11.3.1. Research & Development (R&D)
  • 11.3.2. GMP and Commercial Production
• 11.4. Market Attractiveness Analysis By Application

12. Global Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2032
  • 12.3.1. Biopharmaceutical Companies
  • 12.3.2. Contract Research Organizations
  • 12.3.3. Contract Manufacturing Organizations
  • 12.3.4. Research Institute
• 12.4. Market Attractiveness Analysis By End User

13. Global Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) and Volume ('000 Unit) Analysis By Region, 2019-2023
• 13.3. Current Market Size (US$ Bn) and Volume ('000 Unit) Analysis and Forecast By Region, 2024-2032
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis By Region

14. North America Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Component
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Component
  • 14.4.2. By Application
  • 14.4.3. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. U.S. Single-use Bioprocess Systems Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Component
      • 14.8.1.2.2. By Application
      • 14.8.1.2.3. By End User
  • 14.8.2. Canada Single-use Bioprocess Systems Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Component
      • 14.8.2.2.2. By Application
      • 14.8.2.2.3. By End User

15. Latin America Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Component
  • 15.3.3. By Application
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Component
  • 15.4.3. By Application
  • 15.4.4. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Brazil Single-use Bioprocess Systems Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Component
      • 15.8.1.2.2. By Application
      • 15.8.1.2.3. By End User
  • 15.8.2. Mexico Single-use Bioprocess Systems Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Component
      • 15.8.2.2.2. By Application
      • 15.8.2.2.3. By End User
  • 15.8.3. Argentina Single-use Bioprocess Systems Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Component
      • 15.8.3.2.2. By Application
      • 15.8.3.2.3. By End User

16. Europe Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Nordic Countries
    • 16.3.1.8. Russia
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Component
  • 16.3.3. By Application
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Component
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Single-use Bioprocess Systems Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Component
      • 16.8.1.2.2. By Application
      • 16.8.1.2.3. By End User
  • 16.8.2. Italy Single-use Bioprocess Systems Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Component
      • 16.8.2.2.2. By Application
      • 16.8.2.2.3. By End User
  • 16.8.3. France Single-use Bioprocess Systems Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Component
      • 16.8.3.2.2. By Application
      • 16.8.3.2.3. By End User
  • 16.8.4. U.K. Single-use Bioprocess Systems Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Component
      • 16.8.4.2.2. By Application
      • 16.8.4.2.3. By End User
  • 16.8.5. Spain Single-use Bioprocess Systems Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Component
      • 16.8.5.2.2. By Application
      • 16.8.5.2.3. By End User
  • 16.8.6. BENULUX Single-use Bioprocess Systems Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Component
      • 16.8.6.2.2. By Application
      • 16.8.6.2.3. By End User
  • 16.8.7. Nordic Countries Single-use Bioprocess Systems Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Component
      • 16.8.7.2.2. By Application
      • 16.8.7.2.3. By End User
  • 16.8.8. Russia Single-use Bioprocess Systems Market
    • 16.8.8.1. Introduction
    • 16.8.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.8.2.1. By Component
      • 16.8.8.2.2. By Application
      • 16.8.8.2.3. By End User

17. South Asia Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Philippines
    • 17.3.1.6. Vietnam
    • 17.3.1.7. Rest of South Asia
  • 17.3.2. By Component
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Component
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Single-use Bioprocess Systems Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Component
      • 17.8.1.2.2. By Application
      • 17.8.1.2.3. By End User
  • 17.8.2. Thailand Single-use Bioprocess Systems Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Component
      • 17.8.2.2.2. By Application
      • 17.8.2.2.3. By End User
  • 17.8.3. Indonesia Single-use Bioprocess Systems Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Component
      • 17.8.3.2.2. By Application
      • 17.8.3.2.3. By End User
  • 17.8.4. Malaysia Single-use Bioprocess Systems Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Component
      • 17.8.4.2.2. By Application
      • 17.8.4.2.3. By End User
  • 17.8.5. Philippines Single-use Bioprocess Systems Market
    • 17.8.5.1. Introduction
    • 17.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.5.2.1. By Component
      • 17.8.5.2.2. By Application
      • 17.8.5.2.3. By End User
  • 17.8.6. Vietnam Single-use Bioprocess Systems Market
    • 17.8.6.1. Introduction
    • 17.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.6.2.1. By Component
      • 17.8.6.2.2. By Application
      • 17.8.6.2.3. By End User

18. East Asia Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Component
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Component
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. China Single-use Bioprocess Systems Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Component
      • 18.8.1.2.2. By Application
      • 18.8.1.2.3. By End User
  • 18.8.2. Japan Single-use Bioprocess Systems Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Component
      • 18.8.2.2.2. By Application
      • 18.8.2.2.3. By End User
  • 18.8.3. South Korea Single-use Bioprocess Systems Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Component
      • 18.8.3.2.2. By Application
      • 18.8.3.2.3. By End User

19. Oceania Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Component
  • 19.3.3. By Application
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Component
  • 19.4.3. By Application
  • 19.4.4. By End User
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. Australia Single-use Bioprocess Systems Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Component
      • 19.8.1.2.2. By Application
      • 19.8.1.2.3. By End User
  • 19.8.2. New Zealand Single-use Bioprocess Systems Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Component
      • 19.8.2.2.2. By Application
      • 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Single-use Bioprocess Systems Market Analysis 2019-2023 and Forecast 2024-2032

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Trend Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Component
  • 20.3.3. By Application
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Component
  • 20.4.3. By Application
• 20.5. Market Trends
• 20.6. Key Market Participants - Intensity Mapping
• 20.7. Drivers and Restraints - Impact Analysis
• 20.8. Country Level Analysis & Forecast
  • 20.8.1. GCC Countries Single-use Bioprocess Systems Market
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.1.2.1. By Component
      • 20.8.1.2.2. By Application
      • 20.8.1.2.3. By End User
  • 20.8.2. Turkey Single-use Bioprocess Systems Market
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.2.2.1. By Component
      • 20.8.2.2.2. By Application
      • 20.8.2.2.3. By End User
  • 20.8.3. South Africa Single-use Bioprocess Systems Market
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.3.2.1. By Component
      • 20.8.3.2.2. By Application
      • 20.8.3.2.3. By End User
  • 20.8.4. North Africa Single-use Bioprocess Systems Market
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.8.4.2.1. By Component
      • 20.8.4.2.2. By Application
      • 20.8.4.2.3. By End User

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis
  • 21.3.1. Regional footprint of Players
  • 21.3.2. Product footprint by Players
  • 21.3.3. Channel footprint by Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. Thermo Fisher Scientific Inc.
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Key Financials
    • 22.3.1.4. Sales Footprint
    • 22.3.1.5. SWOT Analysis
    • 22.3.1.6. Key Developments
    • 22.3.1.7. Strategy Overview
      • 22.3.1.7.1. Channel Strategy
      • 22.3.1.7.2. Marketing Strategy
      • 22.3.1.7.3. Product Strategy
  • 22.3.2. Sartorius Stedim Biotech
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Key Financials
    • 22.3.2.4. Sales Footprint
    • 22.3.2.5. SWOT Analysis
    • 22.3.2.6. Key Developments
    • 22.3.2.7. Strategy Overview
      • 22.3.2.7.1. Channel Strategy
      • 22.3.2.7.2. Marketing Strategy
      • 22.3.2.7.3. Product Strategy
  • 22.3.3. Danaher Corporation
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Key Financials
    • 22.3.3.4. Sales Footprint
    • 22.3.3.5. SWOT Analysis
    • 22.3.3.6. Key Developments
    • 22.3.3.7. Strategy Overview
      • 22.3.3.7.1. Channel Strategy
      • 22.3.3.7.2. Marketing Strategy
      • 22.3.3.7.3. Product Strategy
  • 22.3.4. Merck KGaA
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Key Financials
    • 22.3.4.4. Sales Footprint
    • 22.3.4.5. SWOT Analysis
    • 22.3.4.6. Key Developments
    • 22.3.4.7. Strategy Overview
      • 22.3.4.7.1. Channel Strategy
      • 22.3.4.7.2. Marketing Strategy
      • 22.3.4.7.3. Product Strategy
  • 22.3.5. Corning
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Key Financials
    • 22.3.5.4. Sales Footprint
    • 22.3.5.5. SWOT Analysis
    • 22.3.5.6. Key Developments
    • 22.3.5.7. Strategy Overview
      • 22.3.5.7.1. Channel Strategy
      • 22.3.5.7.2. Marketing Strategy
      • 22.3.5.7.3. Product Strategy
  • 22.3.6. Avantor
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Key Financials
    • 22.3.6.4. Sales Footprint
    • 22.3.6.5. SWOT Analysis
    • 22.3.6.6. Key Developments
    • 22.3.6.7. Strategy Overview
      • 22.3.6.7.1. Channel Strategy
      • 22.3.6.7.2. Marketing Strategy
      • 22.3.6.7.3. Product Strategy
  • 22.3.7. CESCO Bioengineering Co. Ltd.
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Key Financials
    • 22.3.7.4. Sales Footprint
    • 22.3.7.5. SWOT Analysis
    • 22.3.7.6. Key Developments
    • 22.3.7.7. Strategy Overview
      • 22.3.7.7.1. Channel Strategy
      • 22.3.7.7.2. Marketing Strategy
      • 22.3.7.7.3. Product Strategy
  • 22.3.8. PBS Biotech, Inc.
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Key Financials
    • 22.3.8.4. Sales Footprint
    • 22.3.8.5. SWOT Analysis
    • 22.3.8.6. Key Developments
    • 22.3.8.7. Strategy Overview
      • 22.3.8.7.1. Channel Strategy
      • 22.3.8.7.2. Marketing Strategy
      • 22.3.8.7.3. Product Strategy
  • 22.3.9. Distek, Inc.
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Key Financials
    • 22.3.9.4. Sales Footprint
    • 22.3.9.5. SWOT Analysis
    • 22.3.9.6. Key Developments
    • 22.3.9.7. Strategy Overview
      • 22.3.9.7.1. Channel Strategy
      • 22.3.9.7.2. Marketing Strategy
      • 22.3.9.7.3. Product Strategy
  • 22.3.10. Eppendorf AG
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Key Financials
    • 22.3.10.4. Sales Footprint
    • 22.3.10.5. SWOT Analysis
    • 22.3.10.6. Key Developments
    • 22.3.10.7. Strategy Overview
      • 22.3.10.7.1. Channel Strategy
      • 22.3.10.7.2. Marketing Strategy
      • 22.3.10.7.3. Product Strategy
  • 22.3.11. Celltainer Biotech B.V.
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Key Financials
    • 22.3.11.4. Sales Footprint
    • 22.3.11.5. SWOT Analysis
    • 22.3.11.6. Key Developments
    • 22.3.11.7. Strategy Overview
      • 22.3.11.7.1. Channel Strategy
      • 22.3.11.7.2. Marketing Strategy
      • 22.3.11.7.3. Product Strategy
  • 22.3.12. Getinge (Applikon Biotechnology)
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Key Financials
    • 22.3.12.4. Sales Footprint
    • 22.3.12.5. SWOT Analysis
    • 22.3.12.6. Key Developments
    • 22.3.12.7. Strategy Overview
      • 22.3.12.7.1. Channel Strategy
      • 22.3.12.7.2. Marketing Strategy
      • 22.3.12.7.3. Product Strategy
  • 22.3.13. Cellexus Ltd.
    • 22.3.13.1. Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Key Financials
    • 22.3.13.4. Sales Footprint
    • 22.3.13.5. SWOT Analysis
    • 22.3.13.6. Key Developments
    • 22.3.13.7. Strategy Overview
      • 22.3.13.7.1. Channel Strategy
      • 22.3.13.7.2. Marketing Strategy
      • 22.3.13.7.3. Product Strategy
  • 22.3.14. Parker Hannifin Corp
    • 22.3.14.1. Overview
    • 22.3.14.2. Product Portfolio
    • 22.3.14.3. Key Financials
    • 22.3.14.4. Sales Footprint
    • 22.3.14.5. SWOT Analysis
    • 22.3.14.6. Key Developments
    • 22.3.14.7. Strategy Overview
      • 22.3.14.7.1. Channel Strategy
      • 22.3.14.7.2. Marketing Strategy
      • 22.3.14.7.3. Product Strategy
  • 22.3.15. Mettler-Toledo International, Inc.
    • 22.3.15.1. Overview
    • 22.3.15.2. Product Portfolio
    • 22.3.15.3. Key Financials
    • 22.3.15.4. Sales Footprint
    • 22.3.15.5. SWOT Analysis
    • 22.3.15.6. Key Developments
    • 22.3.15.7. Strategy Overview
      • 22.3.15.7.1. Channel Strategy
      • 22.3.15.7.2. Marketing Strategy
      • 22.3.15.7.3. Product Strategy

23. Assumptions and Acronyms Used

24. Research Methodology